This article serves as a resource for practicing clinicians, summarizing the 2017 ACC/AHA Hypertension Guideline's evidence-based approach to reducing cardiovascular disease risk through blood pressure control.
Ideas and Opinions6 March 2018The 2017 American College of Cardiology/American Heart Association Hypertension Guideline: A Resource for Practicing CliniciansRobert M. Carey, MD and Paul K. Whelton, MB, MD, MScRobert M. Carey, MDUniversity of Virginia Health System, Charlottesville, Virginia (R.M.C.) and Paul K. Whelton, MB, MD, MScTulane University School of Public Health and Tropical Medicine and Tulane University School of Medicine, New Orleans, Louisiana (P.K.W.)Author, Article, and Disclosure Informationhttps://doi.org/10.7326/M18-0025 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Hypertension is the leading risk factor for death and disability worldwide (1, 2). The 2017 American College of Cardiology (ACC)/American Heart Association (AHA) Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (3) is the first comprehensive clinical practice guideline for hypertension since the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) in 2003 (4). The ACC/AHA guideline provides an evidence-based approach to reducing risk for cardiovascular disease (CVD) by controlling blood pressure (BP) (3).Four of the core recommendations for CVD risk reduction ...References1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224-60. [PMID: 23245609] doi:10.1016/S0140-6736(12)61766-8 CrossrefMedlineGoogle Scholar2. Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990–2015. JAMA. 2017;317:165-182. [PMID: 28097354] doi:10.1001/jama.2016.19043 CrossrefMedlineGoogle Scholar3. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2017. [PMID: 29133356] doi:10.1161/HYP.0000000000000065 CrossrefMedlineGoogle Scholar4. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-52. [PMID: 14656957] CrossrefMedlineGoogle Scholar5. Muntner P, Carey RM, Gidding S, Jones DW, Taler SJ, Wright JT, et al. Potential U.S. population impact of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline. Circulation. 2017. [PMID: 29133599] doi:10.1161/CIRCULATIONAHA.117.032582 CrossrefMedlineGoogle Scholar6. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2017. [PMID: 29133354] doi:10.1161/HYP.0000000000000066 CrossrefMedlineGoogle Scholar7. Carey RM, Whelton PK; 2017 ACC/AHA Hypertension Guideline Writing Committee. Prevention, detection, evaluation, and management of high blood pressure in adults: synopsis of the 2017 American College of Cardiology/American Heart Association hypertension guideline. Ann Intern Med. 2018;168:351-8. doi:10.7326/M17-3203 LinkGoogle Scholar8. Greenland P. Cardiovascular guideline skepticism vs lifestyle realism? JAMA. 2017. [PMID: 29242938] doi:10.1001/jama.2017.19675 CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: University of Virginia Health System, Charlottesville, Virginia (R.M.C.)Tulane University School of Public Health and Tropical Medicine and Tulane University School of Medicine, New Orleans, Louisiana (P.K.W.)Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M18-0025.Corresponding Author: Robert M. Carey, MD, University of Virginia Health System, PO Box 801414, Charlottesville, VA 22908-1414.Current Author Addresses: Dr. Carey: University of Virginia Health System, PO Box 801414, Charlottesville, VA 22908-1414.Dr. Whelton: Tulane University School of Public Health and Tropical Medicine and Tulane School of Medicine, 1440 Canal Street, New Orleans, LA 70112.Author Contributions: Conception and design: R.M. Carey, P.K. Whelton.Analysis and interpretation of the data: R.M. Carey, P.K. Whelton.Drafting of the article: R.M. Carey.Critical revision of the article for important intellectual content: R.M. Carey, P.K. Whelton.Final approval of the article: R.M. Carey, P.K. Whelton.Administrative, technical, or logistic support: R.M. Carey, P.K. Whelton.Collection and assembly of data: P.K. Whelton.This article was published at Annals.org on 23 January 2018. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoPrevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Synopsis of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline Robert M. Carey , Paul K. Whelton , and Hypertension Limbo: Balancing Benefits, Harms, and Patient Preferences Before We Lower the Bar on Blood Pressure Timothy J. Wilt , Devan Kansagara , Amir Qaseem , and Metrics Cited byBehavioural Economics to Improve Antihypertensive Therapy Adherence (BETA): protocol for a pilot randomised controlled trial in Los AngelesFactors Associated with Antiretroviral Therapy Toxicity Out-Comes in Patients with and without HypertensionUrine 11-Dehydro-Thromboxane B2 in Aspirin-Naive Males with Metabolic SyndromeHypothesis: Accessory renal arteries may be an overlooked cause of renin-dependent hypertensionCardiovascular Disease Screening in Women: Leveraging Artificial Intelligence and Digital ToolsThreshold Effects of Total Copper Intake on Cognitive Function in US Older Adults and the Moderating Effect of Fat and Saturated Fatty Acid IntakeEffect of Serum Urate Lowering With Allopurinol on Blood Pressure in Young Adults: A Randomized, Controlled, Crossover TrialAssociation between visceral/subcutaneous adipose tissue ratio and plasma inflammatory markers and score for cardiovascular risk prediction in a Brazilian cohort: Pró-Saúde StudyResults of primary health care intervention for prevention of hospitalizations and mortality due to hypertension in Brazil, 2000–2015Association of Estimated Insulin Resistance with N-Terminal B-Type Natriuretic Peptide Concentration in Men with Metabolic SyndromeRelationship between a Weighted Multi-Gene Algorithm and Blood Pressure Control in HypertensionReaching for Goal: Incorporating the Latest Hypertension Guidelines Into PracticeThe Effect of Genetically Guided Mathematical Prediction and the Blood Pressure Response to Pharmacotherapy in Hypertension PatientsEconomic evaluation of a pharmacogenomic multi-gene panel test to optimize anti-hypertension therapy: simulation studyChallenges and dilemmas on universal coverage for non-communicable diseases in middle-income countries: evidence and lessons from MexicoThe Burden of Modifiable Risk Factors in Newly Defined Categories of Blood PressureDiabetes mellitus and cardiovascular risk: Update of the recommendations of the Diabetes and Cardiovascular Disease working group of the Spanish Diabetes Society (SED, 2018)Diabetes mellitus y riesgo cardiovascular. Actualización de las recomendaciones del Grupo de Trabajo de Diabetes y Riesgo Cardiovascular de la Sociedad Española de Diabetes (SED, 2018) 6 March 2018Volume 168, Issue 5Page: 359-360KeywordsAntihypertensive drug therapyAtherosclerotic cardiovascular diseaseCardiovascular diseasesHypertensionOverweightPrimary hypertensionQuality improvementSodiumTelemedicineTreatment guidelines ePublished: 23 January 2018 Issue Published: 6 March 2018 Copyright & PermissionsCopyright © 2018 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Carey et al. (2018) conducted an editorial in Hypertension. 2017 ACC/AHA Hypertension Guideline was evaluated. The 2017 ACC/AHA guideline provides an evidence-based approach to reducing risk for cardiovascular disease by controlling blood pressure, serving as the first comprehensive guideline since 2003.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: